Failure of Medical Therapy in Pulmonary Arterial Hypertension Is There an Alternative Diagnosis?

被引:21
|
作者
Harch, Susan [1 ]
Whitford, Helen [2 ]
McLean, Catriona [1 ]
机构
[1] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia
[2] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3181, Australia
关键词
VENOOCCLUSIVE DISEASE; PROSTACYCLIN; BOSENTAN; EDEMA;
D O I
10.1378/chest.08-2006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Despite the development of targeted therapies for pulmonary arterial hypertension (PAH), some patients fail to respond to medical therapy. There are a number of types of PAH, one of which is pulmonary venoocclusive disease (PVOD). Unlike other PAH types, the hallmark pathology of PVOD is fibrous occlusion of the small venules, potentially with arterial involvement. It was hypothesized that a lack of response to medical therapy in clinically diagnosed PAH can be explained by misdiagnosed PVOD. Methods: This study reviewed cases of 14 patients with clinically diagnosed PAH who had failed to respond to medical therapy and had lung tissue available from autopsy or explant. Control samples (n = 6) were obtained from lungs explanted for other causes, and at previous transthoracic echocardiogram excluded pulmonary hypertension. Comprehensive vessel morphometry was performed, and the clinical data reviewed. Results: Vessel analysis confirmed 86% of case patients had PVOD and 14% had arterial-only PAH (artPAH). In the PVOD case patients, significant pathology was present in all vessel types with similar obstructive, intimal fibrosis in the venules (p < 0.0001) and arterioles (p < 0.0001). This was considerably different from the intimal concentric laminar smooth muscle proliferation in the artPAH cases. There were no significant differences in clinical presentation between PVOD and artPAH case patients. Pulmonary edema was not observed in the PVOD cases. Conclusions: PVOD is an underdiagnosed and commonly, misdiagnosed cause of pulmonary hypertension, which may present with a failure to respond to medical therapy. Further studies on PVOD may help confirm whether a change in its classification as a type of PAH is necessary. (CHEST 2009; 135:1462-1469)
引用
收藏
页码:1462 / 1469
页数:8
相关论文
共 50 条
  • [31] Pulmonary arterial hypertension: diagnosis and treatment
    Sadowski, Marcin
    Janion-Sadowska, Agnieszka
    Letek, Agnieszka
    Raczynski, Grzegorz
    Zandecki, Lukasz
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2013, 29 (03) : 273 - 279
  • [32] Pulmonary Arterial Hypertension: Diagnosis and Treatment
    Barnett, Christopher F.
    Alvarez, Paulino
    Park, Myung H.
    CARDIOLOGY CLINICS, 2016, 34 (03) : 375 - +
  • [33] A Diagnosis at Hand: Pulmonary Arterial Hypertension
    Khaira, Kavita
    Allen, Roblee
    Amsterdam, Ezra A.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08): : 812 - 815
  • [34] Diagnosis and management of pulmonary arterial hypertension
    Cullivan, Sarah
    Higgins, Margaret
    Gaine, Sean
    BREATHE, 2022, 18 (04)
  • [35] Diagnosis and Management of Pulmonary Arterial Hypertension
    Houtchens, Jeanne
    Martin, Douglas
    Klinger, James R.
    PULMONARY MEDICINE, 2011, 2011
  • [36] Diagnosis and classification of pulmonary arterial hypertension
    Provencher, S
    Martel, S
    Jais, X
    Sitbon, O
    Humbert, M
    Simonneau, G
    PRESSE MEDICALE, 2005, 34 (19): : 1435 - 1444
  • [37] Diagnosis and Assessment of Pulmonary Arterial Hypertension
    Badesch, David B.
    Champion, Hunter C.
    Gomez Sanchez, Miguel Angel
    Hoeper, Marius M.
    Loyd, James E.
    Manes, Alessandra
    McGoon, Michael
    Naeije, Robert
    Olschewski, Horst
    Oudiz, Ronald J.
    Torbicki, Adam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) : S55 - S66
  • [38] Diagnosis and treatment of pulmonary arterial hypertension
    Channick, R
    Williamson, TL
    CARDIOLOGY CLINICS, 2004, 22 (03) : 441 - +
  • [39] Metformin Therapy for Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction versus Pulmonary Arterial Hypertension
    Goncharov, Dmitry A.
    Goncharova, Elena A.
    Tofovic, Stevan P.
    Hu, Jian
    Baust, Jeff J.
    Pena, Andressa Z.
    Ray, Arnab
    Rode, Analise
    Vanderpool, Rebecca R.
    Mora, Ana L.
    Gladwin, Mark T.
    Lai, Yen-Chun
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (05) : 681 - 684
  • [40] Combination Therapy for Pulmonary Arterial Hypertension
    Roman Broto, Antonio
    Monforte Torres, Victor
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (01): : 36 - 40